In particular, we highlight the eminent role of the osteoprotegerin (OPG)-receptor activator of nuclear factor-κB (RANK)-RANK ligand (RANKL) system in the development of CN. This evidence concerns the gene TNFRSF11A and cyclic hematopoiesis.